Signals
The ovaries were never the whole story: PMOS linked to heart attacks and strokes in more than two million women
The largest US study of its kind found that women aged 18 to 50 with polyendocrine metabolic ovarian syndrome, formerly known as PCOS, had substantially higher rates of heart attack, stroke and peripheral artery disease. The risk remained elevated after researchers accounted for obesity, diabetes, hypertension and abnormal cholesterol. The findings expose a healthcare model…
Merck KGaA’s Saturnus Bio bet signals a shift to genotype-driven cardiology, and a looming readiness gap for health systems
Same country, different risks: why Iranian women’s heart disease profiles expose a blind spot in prevention policy
Migraine Prevention Gets a Wider Door
Cyclospora Is Spreading. The Food Chain Still Has No Answer.
Indigenous cardiovascular inequity is not a data gap. It is a policy failure
Menopause is a cardiometabolic checkpoint. Health systems still treat it like a hormone debate
Alzheimer’s Trials Are Finally Blood-Gated
Europe Can Forecast Vibrio Risk. It Still Has To Act.
Cardiology has too many dashboards. The danger is forgetting the patient
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.